导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -10.75% | 3799/4773 |
| 近一周 | -1.47% | 2195/5465 |
| 近一月 | -7.51% | 4573/5421 |
| 近一季 | -16.87% | 4528/5231 |
| 近半年 | -19.27% | 4342/4920 |
| 近一年 | -5.18% | 3161/4394 |
| 近两年 | 36.89% | 2036/2954 |
| 近三年 | 6.82% | 1811/2253 |
| 成立以来 | 113.38% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.29% 546/4961 |
1.52% 3014/5312 |
- - |
- - |
| 2025 | 28.28% 1493/4813 |
-3.93% 3106/3635 |
0.28% 2716/4076 |
35.10% 1004/4524 |
-1.44% 2933/4813 |
| 2024 | 2.50% 1971/3463 |
-2.21% 1334/2808 |
-7.53% 2095/3014 |
18.04% 1069/3129 |
-3.97% 2412/3463 |
| 2023 | -28.47% 2039/2656 |
-2.67% 2037/2280 |
-5.43% 1453/2385 |
-14.57% 2188/2515 |
-9.03% 2321/2655 |
| 2022 | -23.01% 1108/2207 |
-14.72% 990/1919 |
13.95% 214/2016 |
-15.55% 1314/2113 |
-6.18% 1983/2208 |
| 2021 | 50.91% 1/1822 |
-3.26% 789/1255 |
30.06% 43/1330 |
18.74% 59/1466 |
1.02% 1022/1822 |
| 2020 | 62.22% 117/1250 |
-4.52% 371/1028 |
16.10% 457/1067 |
20.14% 60/1164 |
21.80% 51/1184 |
| 2019 | 24.57% 615/1092 |
25.58% 454/754 |
-9.72% 684/804 |
1.50% 394/850 |
8.26% 329/918 |
| 2018 | -36.94% 591/834 |
- - |
- - |
- - |
-9.07% 119/691 |
| 2017 | 0.40% 479/714 |
- - |
- - |
- - |
- - |
| 2016 | -15.76% 364/605 |
- - |
- - |
- - |
- - |
| 2015 | 30.51% 74/575 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 申万菱信中证环保产业指数(LOF)A VS. 长安沪深300非周期A(740101) |